Real World Evidence Analytics Solution
WinWire Technologies · Intelligence & Research
Certification per Microsoft Marketplace.
Evidence tier Source Confirmed · 8 captures on record
What the publisher says
As described on Microsoft Marketplace.
In today’s data-driven world, exploring real-world data (RWD) and making it actionable to drive value across the clinical and commercial continuum is a significant challenge many life sciences organizations struggle with.
Organizations have realized that unlocking the value from RWD is the way forward for the industry to achieve accelerated clinical trials and support regulatory decisions. Healthcare Teams need the right evidence to demonstrate the value of products and inform complex healthcare decisions.
Show the rest of the publisher’s description (16 more lines)
WinWire’s Real World Evidence (RWE) Analytics solution is powered by Knowledge Mining and is built by leveraging Azure Search, Cognitive Services, NLP/AI, and Text Analytics. The solution transforms data into insights and facilitates RWE by enabling organizations to ingest vast datasets from various sources and provide analytical tools, including AI capabilities.
How it works
- Ingest – Extracts data from sources of RWD to Azure-based data storage securely
- Analyze and Manage – Manage and store data in a centralized location
- Knowledge Mining – Understands, learns analyzes, unifies volumes of data to uncover hidden insights
- Visualize – Extracted data is visualized to identify what actions will lead to positive customer outcomes
- Act – Operationalize insights into meaningful actions that derive value for customers
Key deliverables
- Pretrained Azure Cognitive Services across text, video, and OCR
- Accelerated R&D productivity through secure data collaboration and governance
- Live demo with clinical data
Business value
- Enable drug discovery organizations highlight the benefit/s of launched drug with real evidence
- Helps improve patient outcomes
- Improves customer satisfaction with data-driven insights on the drug
- Accelerates clinical trials process
Preview
1 image
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Compliance
- FedRAMPConfirmedNot listed90%, registry-checkedNo FedRAMP Marketplace entry matched this vendor's domain, checked 2026-08-27registry recordas observed 2026-08-27
Confirmed means matched to a public authoritative registry. Claimed means the vendor or its listing states it, not yet cross-checked. A framework not shown was not found in any source we hold, which is not evidence against it. Not listed means a scoped registry check found no match for this vendor's domain: a No is a scoped registry check, not a compliance judgment. Confidence bands: 95% domain-verified, 90% registry-checked, 80% self-attested, 70% weak signal. Self-attested items marked “vendor's site” are gathered from the vendor's own website and are not verified by us.
Vendor
External enrichment · as of 2026-08-29
Sources
Publisher resources
2 linksLinked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.